Literature DB >> 21897470

Clinical variables and platelet mao in schizophrenia.

I Sharma1, A Kumar, J P Chansouria, S L Varma.   

Abstract

Platelet MAO activity was estimated in 60 male drug free schizophrenics and 26 controls matched for age. The paranoid group had significantly lower enzyme activity than the non-paranoid group and controls. Patients with premorbid schizoid personality had significantly lower enzyme activity than patients with non-schizoid premorbid personality and controls. A significant negative correlation between platelet MAO activity and severity and duration of illness was observed. Family history of schizophrenia, presence of auditory hallucinations and type and age of onset of illness were not related to platelet MAO activity.

Entities:  

Year:  1991        PMID: 21897470      PMCID: PMC2988312     

Source DB:  PubMed          Journal:  Indian J Psychiatry        ISSN: 0019-5545            Impact factor:   1.759


  17 in total

1.  Platelet monoamine oxidase activity during the course of a schizophreniform psychosis.

Authors:  I B Cookson; F Owen; A P Ridges
Journal:  Psychol Med       Date:  1975-08       Impact factor: 7.723

2.  Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients.

Authors:  J J Schildkraut; J M Herzog; P J Orsulak; S E Edelman; H M Shein; S H Frazier
Journal:  Am J Psychiatry       Date:  1976-04       Impact factor: 18.112

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines.

Authors:  S Takahashi; H Yamane; N Tani
Journal:  Folia Psychiatr Neurol Jpn       Date:  1975

5.  Human platelet MAO in drug-free and medicated schizophrenic patients.

Authors:  A J Friedhoff; J C Miller; J Weisenfreund
Journal:  Am J Psychiatry       Date:  1978-08       Impact factor: 18.112

6.  Platelet monoamine oxidase activity in schizophrenic patients.

Authors:  R E Becker; E G Shaskan
Journal:  Am J Psychiatry       Date:  1977-05       Impact factor: 18.112

7.  Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.

Authors:  J Mann; K M Thomas
Journal:  Br J Psychiatry       Date:  1979-04       Impact factor: 9.319

8.  Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity.

Authors:  D Schalling; M Asberg; G Edman; L Oreland
Journal:  Acta Psychiatr Scand       Date:  1987-08       Impact factor: 6.392

9.  Are paranoid schizophrenics biologically different from other schizophrenics?

Authors:  S G Potkin; H E Cannon; D L Murphy; R J Wyatt
Journal:  N Engl J Med       Date:  1978-01-12       Impact factor: 91.245

10.  Platelet monoamine oxidase in chronic schizophrenic patients.

Authors:  P A Berger; R A Ginsburg; J D Barchas; D L Murphy; R J Wyatt
Journal:  Am J Psychiatry       Date:  1978-01       Impact factor: 18.112

View more
  2 in total

1.  An overview of Indian research in schizophrenia.

Authors:  Parmanand Kulhara; Ruchita Shah; K R Aarya
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

2.  Women psychiatrists in India: A reflection of their contributions.

Authors:  Mamta Sood; Rakesh K Chadda
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.